TROY, N.Y., July 8 /PRNewswire/ -- Evident Technologies, Inc. announced today that it has begun commercial production of its first biotinylated quantum dot fluorophores. The Biotin EviFluor(R) is available in wavelengths from blue to near infrared. The unique quantum dot EviFluor(R) offers significant advantages over traditional fluorophores, and can enable next generation applications in cell biology, drug discovery, cancer research and many other fields. Quantum dots are semiconductor nanocrystals that fluoresce when excited by a light source, emitting bright colors that can identify and track properties and processes in various biological applications. "The Biotin EviFluors(R) offer advantages over traditional fluors and dyes including a wider range of colors, brighter emission, increased stability and help advance research," according to Clint Ballinger, Ph.D., CEO of Evident. "To our knowledge, our Biotin EviFluor is the first biotin quantum dot label produced using three semiconductor materials systems to achieve the widest range of wavelengths including near infrared," said Ballinger. "This allows product developers to create entirely new forms of assays, and has the potential to create a new set of tools for the life science researcher." Biotin EviFluors(R) offer advantages of photostability, which enables long-term analysis, and color multiplexing on a single platform to examine simultaneously multiple variables. EviFluors(R) are easily excited with broad light sources, have sharp emission peaks and no red side tailing. For more information on Biotin EviFluors(R), please go to http://www.evidenttech.com/biotin. "EviFluors are the new quantum dot product that emits out to 900 nm, and is useful for life science applications. The ability to work with material that emits in the NIR decreases background noise in living cell applications. This opens up new opportunities in many life science fields," said Dr. Jeff Li, Researcher, Harvard University. "We have been very encouraged by our work with Evident's new material which has demonstrated increased brightness and less background noise than other quantum dot products. The greater photostability and increased ability to multiplex will enhance the tools we provide to our life science customers for visualization and detection platforms," said Albert Perry, Ph.D., CEO of KPL, Inc. Evident is a leading worldwide commercial source for quantum dot based nanocrystals and a pioneer in developing product applications for the life sciences, solid state lighting, energy, security, telecommunications, and emergent nanotechnology markets. See http://www.evidenttech.com.
SOURCE Evident Technologies, Inc.